NYLIM
RVNC

New York Life Investment Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

New York Life Investment Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-295,670
Closed -$899K – 866
2024
Q4 		$899K Buy
295,670
+158,076
+115% +$481K 0.01% 679
2024
Q3 		$714K Buy
+137,594
New +$714K 0.01% 767